Brain Fog Is Not
a Diagnosis —
What the Organic Acids Test
Reveals About Why Your
Brain Isn't Working

Brain fog is described by the people who experience it with remarkable consistency: a sense of thinking through cotton wool, words that won't come, tasks that require twice the effort for half the quality, a mental latency where there used to be immediacy. It is one of the most common complaints in functional practice — and one of the most dismissed in conventional medicine, where it tends to be attributed to stress, poor sleep, aging, or simply not being as sharp as one imagines oneself to be.

It is not a personality trait. It is not a consequence of having too much on your plate. It is a measurable biochemical state, and it has causes that are identifiable, testable, and in most cases addressable. The difficulty is that brain fog rarely has a single cause — it is almost always the downstream consequence of several overlapping system failures, which is why it responds poorly to single-supplement interventions and why it tends to persist through sleep improvement, dietary changes, and lifestyle optimisation when those changes are made without knowing which system is actually failing.

The Organic Acids Test is the single most useful test for brain fog in functional practice. Not because it diagnoses it — it does not — but because it provides simultaneous windows into the six most common underlying systems: mitochondrial function, neurotransmitter metabolism, methylation, oxidative stress, gut dysbiosis, and detoxification capacity. This post explains what each of those systems contributes to brain function, what the OAT markers look like when they are failing, and what to do about it.

What brain fog actually is —
six overlapping system failures.

Most people with significant brain fog have two or three of these systems operating simultaneously, which is why the symptom is so persistent and so unresponsive to single interventions. The OAT does not fix brain fog. It tells you which of these systems is the primary driver — and that changes everything about what you do next.

The energy problem —
why the brain is the most metabolically expensive organ.

The brain represents approximately 2% of body weight and consumes approximately 20% of total energy production. It has almost no glycogen reserve and no meaningful fat stores — it is entirely dependent on the real-time delivery of glucose and oxygen and the mitochondrial machinery that converts them to ATP. When mitochondrial function is impaired — through B vitamin depletion, oxidative stress, toxin accumulation, or the chronic low-grade inflammation that disrupts the Krebs cycle — the brain is the first organ to register the shortfall as cognitive impairment.

The specific OAT markers that reflect mitochondrial function are the Krebs cycle intermediates: citrate, isocitrate, alpha-ketoglutarate, succinate, fumarate, and malate. When these accumulate — appearing elevated on the OAT — they indicate a blockage in the cycle at that specific point. Each blockage point has a characteristic nutrient cofactor dependency:

• Elevated citrate — often reflects impaired isocitrate dehydrogenase, which requires NAD+ (niacin/B3). Citrate accumulation diverts carbon away from energy production toward fat synthesis — producing fatigue with a tendency toward weight gain despite unchanged diet.
• Elevated succinate — reflects impaired succinate dehydrogenase, which requires FAD (riboflavin/B2), iron, and CoQ10. One of the most common OAT patterns in genuine chronic fatigue — the cycle stalls at exactly the point that generates the most ATP per turn.
• Elevated alpha-ketoglutarate — reflects impaired alpha-ketoglutarate dehydrogenase, which requires lipoic acid, thiamine (B1), and CoQ10. Brain alpha-ketoglutarate excess is associated with excitatory neurotransmitter accumulation — one mechanism behind the "wired but foggy" presentation.
• Elevated malate and fumarate together — often indicates impaired complex I or II of the mitochondrial electron transport chain. This pattern frequently appears after viral illness, in post-COVID presentations, and in people with significant heavy metal accumulation.

The clinical significance of reading these patterns is that the intervention is specific. Elevated succinate does not respond to general energy support — it responds to riboflavin, iron optimisation, and CoQ10 at doses targeted at complex II. Elevated citrate does not respond to the same protocol. Treating all mitochondrial dysfunction with a generic "mitochondrial support" supplement is applying the right category of intervention with entirely the wrong specificity.

The specific gut markers
that appear in brain fog.

The gut-brain axis has a specific and underappreciated role in brain fog that goes beyond the general inflammation connection covered in the depression post. Several gut-derived compounds directly impair neurological function in measurable ways — and the OAT captures several of them directly.

Arabinose — the yeast-brain connection

Arabinose is a five-carbon sugar produced by Candida and certain other fungal organisms in the gut. It appears in the OAT as a marker of yeast overgrowth — but its clinical significance goes further than indicating dysbiosis. Arabinose cross-links to proteins through a process called glycation, impairing their function. In neural tissue, arabinose-mediated protein glycation has been proposed as a mechanism for the cognitive impairment associated with yeast overgrowth. Elevated arabinose on an OAT in a patient with brain fog is one of the highest-yield findings — because yeast overgrowth is addressable, and the cognitive response to antifungal intervention in arabinose-elevated patients is often the most dramatic improvement in the entire clinical picture.

D-lactic acid — bacterial fermentation and brain function

D-lactic acid is produced by certain bacteria — particularly Lactobacillus acidophilus and Lactobacillus fermentum in overgrowth — through carbohydrate fermentation. The human body metabolises L-lactic acid efficiently but lacks adequate D-lactate dehydrogenase to clear D-lactic acid at high production rates. D-lactate accumulates and crosses the blood-brain barrier, producing a state neurologically similar to alcohol intoxication — cognitive slowing, confusion, ataxia, and word-finding difficulty. This is one of the most direct gut-to-brain cognitive impairment mechanisms known and one that is entirely invisible to standard medical investigation. The OAT measures D-lactic acid directly.

Hippuric acid and gut-derived toxin load

Hippuric acid — a detoxification conjugate of benzoic acid — appears elevated when the gut is producing excess benzoate-containing bacterial metabolites that the liver is working to clear. Elevated hippuric acid indicates a significant gut-derived toxic load reaching the liver and competing for the same detoxification capacity the liver uses for everything else — including clearing inflammatory metabolites, oestrogen, and environmental toxins. When hippuric acid is high and glucaric acid (phase 2 detoxification marker) is also elevated, the clinical picture is a liver under sustained load from below — producing systemic cognitive effects as clearance capacity is consumed.

What the OAT actually tells you
about brain chemistry.

The OAT does not measure neurotransmitters directly — it measures their urinary metabolites, which reflect the rate of production and breakdown. The distinction matters: a low 5-HIAA (serotonin metabolite) does not tell you that you have low serotonin in the brain, but it does tell you that serotonin turnover is low — which is a functionally meaningful finding in the context of cognitive impairment, mood, and sleep quality.

The methylation markers on the OAT —
and why they matter for cognitive function.

The OAT provides two functional methylation markers that are more clinically informative than serum B12 and folate for brain fog specifically:

Methylmalonic acid (MMA)

MMA is produced when methylmalonyl-CoA — which should be converted to succinyl-CoA by a B12-dependent enzyme — cannot complete that conversion due to functional B12 insufficiency. Elevated MMA on the OAT indicates functional B12 deficiency at the cellular level, regardless of what serum B12 shows. In the brain, functional B12 deficiency impairs myelin synthesis, reduces SAM availability for neurotransmitter methylation, and slows the methylation cycle — producing cognitive impairment that can be severe and progressive without a serum B12 low enough to flag as deficient in conventional testing. This is one of the most important findings in OAT interpretation for brain fog and cognitive decline.

FIGLU (formiminoglutamic acid)

FIGLU is produced when histidine cannot be properly metabolised due to functional folate insufficiency — the conversion requires 5-MTHF. Elevated FIGLU indicates that folate is not reaching the methylation cycle in adequate active form, regardless of dietary folate intake. In the brain fog context, FIGLU elevation combined with elevated MMA tells you that both halves of the methylation cycle's primary input are functionally insufficient — and that the cognitive impairment is likely to have a significant methylation component that will respond to specific B12 and methylfolate supplementation, not just dietary change.

The markers that show your brain
is fighting chemistry, not thinking.

The final OAT section most relevant to brain fog covers oxidative stress and detoxification capacity. When the brain is under significant oxidative stress — from toxin accumulation, mitochondrial inefficiency, or chronic inflammation — it devotes resources to cellular defence that are not available for cognition. This is the chemical equivalent of a computer running too many background processes: the processing capacity exists but is not available for the tasks you want it to perform.

8-hydroxy-2-deoxyguanosine (8-OHdG)

A marker of oxidative DNA damage — elevated when reactive oxygen species are overwhelming antioxidant defences. In the brain fog context, elevated 8-OHdG suggests mitochondrial and cellular stress that is impacting neuronal integrity. Often elevated in post-viral brain fog and in environmental toxin exposure patterns.

Pyroglutamic acid

Elevated pyroglutamic acid indicates glutathione depletion — the body is running low on its primary antioxidant and detoxification molecule. In the brain, glutathione depletion leaves neurons vulnerable to oxidative damage and impairs the clearance of the toxic metabolites that accumulate during normal neurological activity. Chronically low glutathione produces a progressive background cognitive impairment that worsens with additional oxidative load — stress, alcohol, poor sleep, high inflammatory diet.

Glucaric acid

A marker of Phase 2 liver detoxification demand — elevated when the liver is working hard to conjugate and clear toxins, drugs, hormones, or gut-derived metabolites. When glucaric acid is elevated alongside elevated gut dysbiosis markers, the clinical picture is a liver under dual load from both above (environmental or dietary toxins) and below (gut-derived metabolites) — with the cognitive fog reflecting a detoxification bottleneck rather than a primary brain problem.

What to do with the results —
targeted, not generic.

The value of the OAT for brain fog is not the test itself — it is the specificity of the intervention it enables. Consider the difference between these two OAT patterns:

Pattern A: Elevated succinate, elevated malate, elevated MMA, elevated FIGLU, low 5-HIAA, arabinose elevated, HVA low. This is a mitochondrial complex II dysfunction with functional B12 and folate insufficiency, yeast overgrowth, and low serotonin turnover. The intervention is riboflavin, CoQ10, methylcobalamin B12, methylfolate, antifungal protocol, and tryptophan or 5-HTP support — in that order, sequentially.

Pattern B: Quinolinate elevated, alpha-ketoglutarate elevated, VMA elevated, glucaric acid elevated, pyroglutamic acid elevated, D-lactic acid elevated. This is neuroinflammation with active tryptophan diversion, sympathetic nervous system overactivation, significant liver detoxification demand, glutathione depletion, and bacterial fermentation producing D-lactate. The intervention is anti-inflammatory dietary change, gut bacterial rebalancing, N-acetylcysteine for glutathione support, and HPA regulation — not B vitamins and CoQ10.

Both present as brain fog. Both would be told to "get more sleep, manage stress, and take omega-3." Neither would improve on that advice alone, because the upstream causes are completely different and require completely different interventions.

Practical steps while testing is pending

If you have significant brain fog and have not yet done an OAT, the following steps are low-risk and address the most common underlying patterns without requiring the specificity that testing provides. They will not be sufficient for significant mitochondrial dysfunction or active gut dysbiosis, but they support the systems most commonly involved:

B vitamin complex — specifically methylcobalamin B12 (not cyanocobalamin), methylfolate or folinic acid (not folic acid), and riboflavin at 50–100mg. These are the three most commonly depleted B vitamins in brain fog presentations and support both mitochondrial function and the methylation cycle simultaneously.

Reduce the glucose load on mitochondria — ultra-processed carbohydrates require mitochondria to process large glucose loads rapidly, producing lactate and oxidative stress that compounds existing dysfunction. Stabilising blood sugar through adequate protein, fat, and whole food carbohydrate reduces the demand on an already challenged energy system.

Prioritise gut integrity — fermented foods daily, dietary diversity, reducing antibiotic-adjacent dietary compounds (conventional grain products, excess sugar) supports the gut-brain axis quality that the OAT markers reflect. If arabinose or D-lactate are suspected drivers, a lower-sugar, lower-refined-carbohydrate approach is the first dietary intervention regardless of testing status.